Abstract
Background. Multiple factors have been previously described which could influence adherence to HAART. Our objective is to determine the fundamental factors which influence adherence to highly active antiretroviral therapy in our population. Methods. A cross-sectional study was made selecting 143 outpatients attending our hospital HIV unit. 22 factors were recorded which could influence adherence to treatment (covering individual factors, the illness itself, the therapeutic regimen and the medical team). Adherence was estimated by the combination of two methods (self-report and pharmacy data); statistical analysis was performed using univariate and multivariate methods. Results. 96 patients (67.13%) had good adherence and 47 (32.87%) did not. Only 3 of the 22 factors studied were significant and independent factors related with adherence: employment, housing situation and degree of treatment acceptance. Conclusions. we have found some differences regarding HAART adherence in our population compared with previous studies. Psychosocial and behavioral factors were the principal ones. We must try to detect patients at high risk of nonadherence in order to take therapeutic decisions properly, try to reinforce adherence and modify the factors associated with poor adherence.
Keywords: Highly active antiretroviral therapy, patient compliance, HIV
Current HIV Research
Title: Factors Influencing Adherence to Highly Active Antiretroviral Therapy in Spain
Volume: 4 Issue: 2
Author(s): Leticia Moralejo, Sandra Ines, Miguel Marcos, Aurelio Fuertes and Guillermo Luna
Affiliation:
Keywords: Highly active antiretroviral therapy, patient compliance, HIV
Abstract: Background. Multiple factors have been previously described which could influence adherence to HAART. Our objective is to determine the fundamental factors which influence adherence to highly active antiretroviral therapy in our population. Methods. A cross-sectional study was made selecting 143 outpatients attending our hospital HIV unit. 22 factors were recorded which could influence adherence to treatment (covering individual factors, the illness itself, the therapeutic regimen and the medical team). Adherence was estimated by the combination of two methods (self-report and pharmacy data); statistical analysis was performed using univariate and multivariate methods. Results. 96 patients (67.13%) had good adherence and 47 (32.87%) did not. Only 3 of the 22 factors studied were significant and independent factors related with adherence: employment, housing situation and degree of treatment acceptance. Conclusions. we have found some differences regarding HAART adherence in our population compared with previous studies. Psychosocial and behavioral factors were the principal ones. We must try to detect patients at high risk of nonadherence in order to take therapeutic decisions properly, try to reinforce adherence and modify the factors associated with poor adherence.
Export Options
About this article
Cite this article as:
Moralejo Leticia, Ines Sandra, Marcos Miguel, Fuertes Aurelio and Luna Guillermo, Factors Influencing Adherence to Highly Active Antiretroviral Therapy in Spain, Current HIV Research 2006; 4 (2) . https://dx.doi.org/10.2174/157016206776055075
DOI https://dx.doi.org/10.2174/157016206776055075 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antioxidants and Neuroprotection in the Adult and Developing Central Nervous System
Current Medicinal Chemistry Stem Cell-Based Approaches for Intervertebral Disc Regeneration
Current Stem Cell Research & Therapy Training Pediatric Residents for Intervention on Tobacco
Current Pediatric Reviews Targeting Sphingosine-1-Phosphate Receptors in Cancer
Anti-Cancer Agents in Medicinal Chemistry Adverse Bioeffects of Ultrasound Contrast Agents Used in Echocardiography: True Safety Issue or “Much Ado About Nothing”?
Current Vascular Pharmacology Analysis of Soybean Root Proteins Affected by Gibberellic Acid Treatment Under Flooding Stress
Protein & Peptide Letters Restoration of the Striatal Dopamine Synthesis for Parkinsons Disease:Viral Vector-Mediated Enzyme Replacement Strategy
Current Gene Therapy Major Depressive Disorder and Diabetes: Does Serotonin Bridge the Gap?
Current Diabetes Reviews The Potential Interest of Topiramate in Addictions
Current Pharmaceutical Design Lipid-Based Nanocarriers for CNS-Targeted Drug Delivery
Recent Patents on CNS Drug Discovery (Discontinued) Management of Impulse Control Disorders with Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Formulation and Assessment of In Vivo Anti-Inflammatory Potential of Omega-3-Fatty Acid Loaded Self Emulsifying Nanoemulsion
Current Nanomedicine Molecular Effects of L-dopa Therapy in Parkinson’s Disease
Current Genomics Geniposide Regulates Insulin-Degrading Enzyme Expression to Inhibit the Cytotoxicity of Aβ1-42 in Cortical Neurons
CNS & Neurological Disorders - Drug Targets Risk Factors for Suicide – An Alternative View
CNS & Neurological Disorders - Drug Targets Nanoporous Silica of Some Egyptian Diatom Frustules as a Promising Natural Material
Nanoscience & Nanotechnology-Asia Gene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors
Current Gene Therapy Magnetite Polycitric Acid (Fe3O4@PCA) Nanoparticles: A Novel, Efficient and Reusable Solid Acid Catalyst for the Preparation of Polyhydroquinolines
Letters in Organic Chemistry Structure of Cytochrome P450s and Personalized Drug
Current Medicinal Chemistry Cellular, Molecular and Non-Pharmacological Therapeutic Advances for the Treatment of Parkinson's Disease: Separating Hope from Hype
Current Gene Therapy